Two examples of bio-guided isolation, synthesis and ...
Two examples of bio-guided isolation, synthesis and ...
Two examples of bio-guided isolation, synthesis and ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Two</strong> Examples <strong>of</strong><br />
Bio<strong>guided</strong> Isolation, Synthesis <strong>and</strong> Pharmacomodulation <strong>of</strong><br />
Natural Products from Annonaceae <strong>and</strong> Rutaceae<br />
Dr Bruno FIGADERE<br />
Laboratories <strong>of</strong> Natural Substances Chemistry<br />
(Pharmacognosy), UMR 8076-BioCIS<br />
Faculty <strong>of</strong> Pharmacy, University Paris-Sud<br />
Thai-Franco Seminar on Natural Substances<br />
27 September 2005<br />
BioCIS (UMR CNRS 8076)
Laboratory <strong>of</strong> Chemistry <strong>of</strong> Natural Substances<br />
- Extraction <strong>of</strong> natural products with <strong>bio</strong>logical properties<br />
- Natural products <strong>and</strong> analogues: <strong>synthesis</strong> <strong>and</strong> semi-<strong>synthesis</strong><br />
- Total Synthesis <strong>of</strong> Natural Products<br />
- Antiparasitic Chemiotherapy<br />
BioCIS (UMR CNRS 8076)
Bio<strong>guided</strong> Extraction - Leishmanicidal Compounds:<br />
The Chimanines, 1st Example<br />
- in Bolivia, Galipea longiflora (Rutaceae) is traditionally used<br />
against cutaneous leishmaniasis<br />
- <strong>bio</strong><strong>guided</strong> fractionation <strong>and</strong> purification led to <strong>bio</strong>logical active<br />
alcaloides<br />
N<br />
N<br />
OMe<br />
O<br />
N<br />
N<br />
N<br />
N<br />
O<br />
O<br />
(Fournet, A.et al J. Nat. Prod. 1993, 56, 1547-1552)<br />
BioCIS (UMR CNRS 8076)
Synthesis <strong>of</strong> 2-substituted quinolines (part 1)<br />
H 2 O 2<br />
ClCOOiBu, t he n RMgBr<br />
N<br />
N<br />
O<br />
35-90 %<br />
(Fakhfakh,M.A.. et al Tetrahedron Lett. 2001, 42, 3847)<br />
N<br />
R<br />
N<br />
(67%)<br />
N<br />
(79%)<br />
N<br />
(73%)<br />
N<br />
(53%)<br />
N<br />
(82%)<br />
N<br />
(68%)<br />
N<br />
(63%)<br />
N<br />
(35%)<br />
N<br />
(75%)<br />
SiMe 3<br />
N<br />
(66%)<br />
BioCIS (UMR CNRS 8076)
Synthesis <strong>of</strong> 2-substituted quinolines (part 2)<br />
Wittig<br />
N R N<br />
O<br />
Br<br />
N<br />
(89%)<br />
Br<br />
N<br />
(80%)<br />
CO 2 Et<br />
N<br />
CHO<br />
N<br />
OMe<br />
(64%)<br />
(80%)<br />
N C 5 H 11<br />
N CO 2 Et<br />
(84%) (63%)<br />
BioCIS (UMR CNRS 8076)<br />
N CN N NO 2<br />
(80%) (70%)<br />
(Fakhfakh,M.A. et al Synth. Commun. 2002, 32, 2863)
Synthesis <strong>of</strong> 2- or 3-substituted quinolines (part 3)<br />
N<br />
Cl<br />
RMgX, Fe(acac) 3<br />
THF, -10 °C-0 °C<br />
N<br />
R<br />
N<br />
76%<br />
N<br />
36%<br />
OH<br />
75% N<br />
N<br />
75%<br />
N<br />
70%<br />
(Seck M. et al Tet. Lett. 2004, 45, 1881-1884)<br />
BioCIS (UMR CNRS 8076)
Synthesis <strong>of</strong> 2- substituted quinolines (part 4)<br />
N<br />
OH<br />
Z<br />
F<br />
NO 2<br />
N(CH 3 ) 2<br />
OCH 3<br />
N<br />
H<br />
N<br />
Z<br />
N<br />
O<br />
N<br />
NCH 3<br />
N<br />
OH<br />
CO 2 Me<br />
N<br />
O<br />
Bu<br />
N<br />
O<br />
OEt<br />
N<br />
OH<br />
OMe<br />
OMe<br />
R<br />
N<br />
R<br />
H<br />
Ph<br />
CO 2 Me<br />
N<br />
Z<br />
F<br />
NO 2<br />
N(CH 3 ) 2<br />
OCH 3<br />
N<br />
R<br />
N<br />
N<br />
O<br />
O<br />
n<br />
O<br />
n=1or 7<br />
O<br />
N<br />
N<br />
N<br />
N<br />
O<br />
O<br />
N<br />
N<br />
N<br />
N<br />
BioCIS (UMR CNRS 8076)
In vitro activity <strong>of</strong> synthetic quinolines (IC 50 µM)<br />
L. am az onensis<br />
L. infant um L. donovani<br />
cytotoxicity (macrophages<br />
N<br />
5<br />
32 -<br />
41<br />
N<br />
CHO<br />
4<br />
2 -<br />
9<br />
N<br />
OH<br />
4<br />
2 -<br />
34<br />
N<br />
Br<br />
3<br />
2 -<br />
13<br />
21<br />
32 1,2<br />
40<br />
N<br />
N<br />
CO 2 Me<br />
59<br />
26 3,3<br />
>200<br />
N<br />
37<br />
12 -<br />
74<br />
amphotericine B 0,12<br />
Gluca nt im e 20<br />
pentamidine -<br />
BioCIS (UMR CNRS 8076)<br />
- -<br />
7 -<br />
- 1<br />
-<br />
-<br />
-
In vivo activity <strong>of</strong> synthetic quinolines<br />
L. infantum Balb/c infected mice (10 days treatment by oral administration 2x12.5<br />
mg/kg/d)<br />
Gluca nt im e<br />
% <strong>of</strong> reduction <strong>of</strong> parasites<br />
in the liver<br />
- 65,3<br />
% <strong>of</strong> reduction <strong>of</strong> parasites<br />
in t he s ple e n<br />
+ 6,0%<br />
N<br />
- 1 3,3<br />
+ 95,6<br />
N SiMe 3<br />
- 3 7,8<br />
- 23,8<br />
N<br />
- 60,0<br />
- 47,6<br />
N<br />
OMe<br />
- 6 0,0<br />
- 64,3<br />
N<br />
CHO<br />
- 91,6<br />
- 47,6<br />
N<br />
CH 2 OH<br />
- 51,1<br />
- 3 8,1<br />
N Br<br />
BioCIS (UMR CNRS 8076)<br />
- 24,4 - 33,3<br />
(Fakhfakh, M.A. e t al PCT/FR02/00140 ; PCT Int. Appl. WO 02 57,238 ; CA 2002, 137, 125093m)
Bio<strong>guided</strong> Extraction - Cytotoxic Compounds:<br />
The Acetogenins <strong>of</strong> Annonaceae, 2nd Example<br />
O OH OH<br />
O<br />
1<br />
n<br />
O<br />
S<br />
O<br />
O<br />
O<br />
O<br />
O<br />
O<br />
type A1<br />
O<br />
OH<br />
BioCIS (UMR CNRS 8076)<br />
goniocin (type D1)<br />
OH<br />
reticulatamol (type E)<br />
R, R, R, R : threo-trans-threo<br />
S,R,S,R : threo-cis-threo<br />
n=1, m=3, threo-trans-threo : trans-solamin<br />
n=1, m=3, threo-cis-threo : cis-solamin<br />
n=3, m=3, threo-trans-threo : reticulatacin<br />
n=3, m=3, threo-trans-erythro : reticulatain 1<br />
n=5, m=1, threo-trans-erythro : reticulatain 2<br />
n=5, m=1, threo-trans-threo : uvariamicin 3<br />
OH<br />
OH<br />
O O<br />
O<br />
isomolvizarin (type B2)<br />
OH<br />
O O<br />
Figadère, Cortes et al. Nat. Prod. Rep. 2005, 22, 269-303<br />
m
Acetogenins <strong>of</strong> Annonaceae<br />
O<br />
O<br />
O<br />
OH<br />
O O OH<br />
O<br />
O<br />
O<br />
rolliniastatin 2<br />
OH<br />
O<br />
OH<br />
iso-rolliniastatin 2<br />
antitumoral activity on grafted mice<br />
OH<br />
Products<br />
rolliniastatin 2<br />
iso-rolliniastatin 2<br />
paclitaxel<br />
BioCIS (UMR CNRS 8076)<br />
Quantity(/day)<br />
µg/kg<br />
200<br />
100<br />
50<br />
25<br />
12<br />
800<br />
400<br />
200<br />
100<br />
50<br />
25<br />
25000<br />
17500<br />
15000<br />
7000<br />
4400<br />
% T/C Variation <strong>of</strong> weight<br />
TOX<br />
106<br />
138<br />
125<br />
113<br />
144<br />
144<br />
125<br />
113<br />
113<br />
100<br />
90<br />
105<br />
139<br />
114<br />
117<br />
(g/mouse)<br />
-2,9<br />
-2,6<br />
-0,4<br />
0,6<br />
0,9<br />
0,5<br />
1,1<br />
1,8<br />
1,6<br />
2,1<br />
1,7<br />
-4,4<br />
-2,4<br />
-2,5<br />
-1,1<br />
-0,9
Semi<strong>synthesis</strong>- Perspectives <strong>and</strong> collaborations<br />
Acetogenins <strong>of</strong>’Annonaceae: collaboration with Pasteur Institute, ICSN (Gif-s-Yvette, France)<br />
fluorescent probe (visualisation)<br />
Proteomic<br />
N 3<br />
OR<br />
O<br />
O<br />
OR<br />
O<br />
O<br />
protection, azide formation<br />
OH<br />
OH<br />
O<br />
O<br />
OH<br />
O<br />
O<br />
squamocine<br />
OH<br />
OH<br />
O<br />
KMnO 4<br />
O<br />
OH<br />
OH<br />
R<br />
radical decarboxylation +<br />
O<br />
R<br />
O<br />
R R<br />
OH OH<br />
OH O O<br />
O O<br />
R<br />
BioCIS (UMR CNRS 8076)<br />
R<br />
O<br />
R
Biomimetic Total Synthesis <strong>of</strong> Solamin (part 1)<br />
Z<br />
E<br />
O<br />
O<br />
pseudo- muricadienin<br />
AD-mix β<br />
HO<br />
O<br />
O<br />
OH<br />
oxidation<br />
O<br />
O<br />
O<br />
O<br />
BioCIS (UMR CNRS 8076)<br />
OH<br />
15 R<br />
16 R<br />
O<br />
trans-solamin<br />
or<br />
OH<br />
20 R<br />
19 R<br />
OH OH<br />
15 S<br />
O 20 R<br />
16 S 19 R<br />
cis-solamin<br />
or<br />
diastereomers
Biomimetic Total Synthesis <strong>of</strong> Solamin (part 2)<br />
MeO<br />
O<br />
Z<br />
E<br />
MeO<br />
O<br />
4 steps<br />
Z<br />
Br<br />
+<br />
Metal<br />
E<br />
2 steps<br />
O<br />
O<br />
OH<br />
OH<br />
Figadère, Tetrahedron Lett. 1999, 40, 4041 <strong>and</strong> Let t . Org. Chem . 2004, 1 ,<br />
316-322.<br />
O<br />
BioCIS (UMR CNRS 8076)
Conclusion<br />
- From several plants,<strong>bio</strong>-<strong>guided</strong> <strong>isolation</strong> led to natural 2-substituted quinolines that have shown<br />
promising in vivo activity against a murine model <strong>of</strong> visceral leishmaniasis; <strong>bio</strong><strong>guided</strong> <strong>synthesis</strong><br />
then allowed us to obtain suitable products for preclinical trials<br />
- From several Annonaceae, <strong>bio</strong>-<strong>guided</strong> <strong>isolation</strong> has afforded a series <strong>of</strong> new cytotoxic compounds<br />
the acetogenins <strong>of</strong> Annonaceae; semi-<strong>synthesis</strong>, <strong>and</strong> total <strong>synthesis</strong> gave so far, some information<br />
on the structure-activity relationship, as well as on the cellular target.<br />
BioCIS (UMR CNRS 8076)
BioCIS (UMR CNRS 8076)
BioCIS (UMR CNRS 8076)
BioCIS (UMR CNRS 8076)